Lipella Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LIPO and buy or sell other stocks, ETFs, and their options commission-free!About LIPO
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent.
CEOJonathan Kaufman
CEOJonathan Kaufman
Employees7
Employees7
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2005
Founded2005
Employees7
Employees7
LIPO Key Statistics
Market cap4.79K
Market cap4.79K
Price-Earnings ratio-3.97
Price-Earnings ratio-3.97
Dividend yield—
Dividend yield—
Average volume434.56K
Average volume434.56K
High today$0.0005
High today$0.0005
Low today$0.0005
Low today$0.0005
Open price$0.0005
Open price$0.0005
Volume915.00
Volume915.00
52 Week high$1.50
52 Week high$1.50
52 Week low$0.0005
52 Week low$0.0005
Stock Snapshot
Lipella Pharmaceuticals(LIPO) stock is priced at $0.00, giving the company a market capitalization of 4.79K. It carries a P/E multiple of -3.97.
On 2026-10-24, Lipella Pharmaceuticals(LIPO) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 915, compared to an average daily volume of 434.56K.
Over the past 52 weeks, Lipella Pharmaceuticals(LIPO) stock has traded between a high of $1.50 and a low of $0.00.
Over the past 52 weeks, Lipella Pharmaceuticals(LIPO) stock has traded between a high of $1.50 and a low of $0.00.
People also own
Based on the portfolios of people who own LIPO. This list is generated using Robinhood data, and it’s not a recommendation.